Abound Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Abound Wealth Management's LLY Position: Q2 2026 in Review
Abound Wealth Management reduced its Eli Lilly (LLY) stake by 18% in Q2 2026, selling an estimated $56.2K and leaving 256 shares worth $307K. The position accounts for 0.06% of the portfolio, ranked #74.
Abound Wealth Management first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Abound Wealth Management held 256 shares of Eli Lilly worth $307K as of Q2 2026.
- Abound Wealth Management sold 55 Eli Lilly shares in Q2 2026, an estimated $56.2K.
- Eli Lilly made up 0.06% of Abound Wealth Management's portfolio in Q2 2026, its #74 holding.
- Abound Wealth Management first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.